Literature DB >> 32768481

Trop2 inhibition of P16 expression and the cell cycle promotes intracellular calcium release in OSCC.

Lizhou Jia1, Tengqi Wang2, Guipeng Ding3, Xingwang Kuai1, Xiaolei Wang4, Bin Wang4, Wei Zhao5, Youcai Zhao4.   

Abstract

Trop2 is an intracellular calcium signal transducer and a prognostic biomarker in many cancers. P16 is a cell cycle gene that negatively regulates cell proliferation and division in most human cancers. Oral squamous cell carcinoma (OSCC) is a common malignant tumor subgroup of head and neck squamous cell carcinoma worldwide. Both Ca2+-dependent and cell cycle signaling pathways play vital roles in OSCC, although the molecular mechanisms remain to be elucidated. We aimed to examine the function of Trop2 and P16 in regulating intracellular calcium ions and the cell cycle in OSCC cell lines. Furtherly, the mRNA and protein expression levels of Trop2 and P16 in OSCC tissue samples were assessed, and their function was evaluated as potential clinical prognostic biomarkers. Trop2 promoted intracellular calcium ion release in OSCC and induced S phase of the cell cycle. Moreover, Trop2-mediated Ca2+ inhibited P16 expression through the AMP-activated protein kinase pathway in OSCC. Interestingly, P16 overexpression could not reverse these phenomena in vitro. We also demonstrated that human OSCC tissues showed high Trop2 mRNA and protein expression, and Trop2+/P16- expression is an independent prognostic marker for OSCC patients. Our data suggest that Trop2+/P16- may be a valuable prognostic marker for OSCC and that Trop2 inhibits P16 expression and induces S phase by promoting intracellular calcium release in OSCC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ca(2+); OSCC; P16; PRKAA2; Trop2

Mesh:

Substances:

Year:  2020        PMID: 32768481     DOI: 10.1016/j.ijbiomac.2020.07.234

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

Review 1.  Trop2: Jack of All Trades, Master of None.

Authors:  Sára Lenárt; Peter Lenárt; Jan Šmarda; Ján Remšík; Karel Souček; Petr Beneš
Journal:  Cancers (Basel)       Date:  2020-11-11       Impact factor: 6.639

2.  METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.

Authors:  Yilong Ai; Shiwei Liu; Hailing Luo; Siyuan Wu; Haigang Wei; Zhe Tang; Xia Li; Xiaozhi Lv; Chen Zou
Journal:  J Immunol Res       Date:  2021-08-23       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.